Literature DB >> 15817944

HIV-1 viral protein R (Vpr) & host cellular responses.

Richard Yuqi Zhao1, Michael Bukrinsky, Robert T Elder.   

Abstract

During infection of host cells by HIV-1, active host-pathogen interactions take place. The final balance between these interactions determines the efficiency of viral infection and subsequent disease progression. HIV-infected cells respond to viral invasion with various antiviral strategies such as innate, cellular and humoral immune antiviral defense mechanisms. On the other hand, the virus has also developed tactics to suppress these host cellular responses. Among the many viral offensive strategies, viral protein R (Vpr) plays a particularly active role. Vpr involved in nuclear transport of the viral pre-integration complex, activation of viral transcription, induction of cell cycle G2/M arrest and apoptosis of the host cells. However, specific roles of these Vpr activities in viral pathogenesis and their contribution to disease progression are not fully understood. HIV-1 defective for some or all of these Vpr activities have been associated with slow disease progression in some patients. With regard to the host responses to vpr gene expression, studies show that Vpr is specifically targeted by CD8 T-lymphocytes during acute viral infection and that the host innate immune response may also play a crucial role in suppressing the effects of Vpr on various cellular activities. The effect of host cellular responses to vpr gene expression and its roles in nuclear transport, cell cycle G2/M regulation and induction of apoptosis are discussed in this review. Strategies with potential application for future antiviral therapies directed at suppressing Vpr activities are described.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817944

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  16 in total

1.  Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr.

Authors:  Orly Ardon; Erik S Zimmerman; Joshua L Andersen; Jason L DeHart; Jana Blackett; Vicente Planelles
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  HIV-1 accessory proteins: VpR.

Authors:  Richard Y Zhao; Michael I Bukrinsky
Journal:  Methods Mol Biol       Date:  2014

3.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

4.  HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.

Authors:  Ge Li; Robert T Elder; Larisa Dubrovsky; Dong Liang; Tatiana Pushkarsky; Karen Chiu; Tao Fan; Josephine Sire; Michael Bukrinsky; Richard Y Zhao
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

5.  microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection.

Authors:  Lawrence Carpio; Zachary Klase; William Coley; Irene Guendel; Sarah Choi; Rachel Van Duyne; Aarthi Narayanan; Kylene Kehn-Hall; Laurent Meijer; Fatah Kashanchi
Journal:  J RNAi Gene Silencing       Date:  2010-05-29

6.  Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.

Authors:  Sylvain Huard; Robert T Elder; Dong Liang; Ge Li; Richard Y Zhao
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

7.  HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection.

Authors:  Deepak Kaul; A Ahlawat; S Dutta Gupta
Journal:  Mol Cell Biochem       Date:  2008-12-11       Impact factor: 3.396

8.  Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy.

Authors:  Hailiu Yang; Joseph Nkeze; Richard Y Zhao
Journal:  Cell Biosci       Date:  2012-09-12       Impact factor: 7.133

9.  HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression.

Authors:  Zachary Klase; Rafael Winograd; Jeremiah Davis; Lawrence Carpio; Richard Hildreth; Mohammad Heydarian; Sidney Fu; Timothy McCaffrey; Eti Meiri; Mila Ayash-Rashkovsky; Shlomit Gilad; Zwi Bentwich; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

10.  Impaired nuclear import and viral incorporation of Vpr derived from a HIV long-term non-progressor.

Authors:  Leon Caly; Nitin K Saksena; Sabine C Piller; David A Jans
Journal:  Retrovirology       Date:  2008-07-18       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.